Multi‐Scale Stratification of Metabolomic Profiles for Alzheimer's Subgroup Identification

Abstract

Background: Alzheimer's disease (AD) patients exhibit diverse cognitive impairments, brain atrophy patterns, and pathological hallmarks, suggesting the existence of distinct subtypes. Molecular profiling offers a powerful approach to uncovering this variability and defining clinically relevant subgroups.

The paper